Clinical Trial Update: Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating clonidine for attention-deficit/hyperactivity disorder in children has completed; sponsor is the University of Cincinnati.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: University of Cincinnati | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED